Diabetes and weight-loss trials have shown that the GLP-1 drugs target hormones in the gut and the brain that control appetite and feelings of fullness, cutting down on what's described as food noise, or intrusive thoughts of food
About the Author: Jack Mountain, PharmD Jack Mountain, PharmD, is completing a post-graduate year two (PGY-2) pharmacy residency in ambulatory care at Rhode Island Hospital
January 29, 2025
In fact, Nourish noted in the funding announcement that payers are under growing pressure to find scalable solutions that actually bend the cost curve." The financial strain of GLP-1s is two-fold: payers battle the sheer sticker shock of these medications and the sunk costs when patients discontinue treatment
And hepatic steatosis resolved in greater than 85% of participants with retatrutide 8 mg and 12 mg at week 48. The safety profile of retatrutide in the NAFLD subset was similar to that in the obesity population, and no hepatotoxicity signals in obesity or NAFLD was seen through week 48
Is Peptide Sciences tirzepatide the same as pharmaceutical tirzepatide